CN106038802A - Preparation method of traditional Chinese medicinal composition for treating premature ovarian failure of women and traditional Chinese medicinal composition - Google Patents
Preparation method of traditional Chinese medicinal composition for treating premature ovarian failure of women and traditional Chinese medicinal composition Download PDFInfo
- Publication number
- CN106038802A CN106038802A CN201610443754.3A CN201610443754A CN106038802A CN 106038802 A CN106038802 A CN 106038802A CN 201610443754 A CN201610443754 A CN 201610443754A CN 106038802 A CN106038802 A CN 106038802A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- component
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 206010036601 premature menopause Diseases 0.000 title abstract description 30
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 title abstract description 27
- 208000017942 premature ovarian failure 1 Diseases 0.000 title abstract description 27
- 239000003814 drug Substances 0.000 claims abstract description 164
- 229940079593 drug Drugs 0.000 claims abstract description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000000706 filtrate Substances 0.000 claims abstract description 14
- 239000011347 resin Substances 0.000 claims abstract description 11
- 229920005989 resin Polymers 0.000 claims abstract description 11
- 239000002775 capsule Substances 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000012153 distilled water Substances 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 238000010521 absorption reaction Methods 0.000 claims abstract description 4
- 239000008367 deionised water Substances 0.000 claims abstract description 4
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 4
- 230000006837 decompression Effects 0.000 claims abstract description 3
- 238000011282 treatment Methods 0.000 claims description 35
- 239000000829 suppository Substances 0.000 claims description 30
- 210000001672 ovary Anatomy 0.000 claims description 24
- 210000000582 semen Anatomy 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 14
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 239000002674 ointment Substances 0.000 claims description 7
- 238000005325 percolation Methods 0.000 claims description 7
- 229920000742 Cotton Polymers 0.000 claims description 6
- 229910000831 Steel Inorganic materials 0.000 claims description 6
- 238000007493 shaping process Methods 0.000 claims description 6
- 239000010959 steel Substances 0.000 claims description 6
- 235000019640 taste Nutrition 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- 244000025254 Cannabis sativa Species 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 241000700605 Viruses Species 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000013521 mastic Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 229960000502 poloxamer Drugs 0.000 claims description 3
- 229920001983 poloxamer Polymers 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 241000143437 Aciculosporium take Species 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 238000010410 dusting Methods 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 238000004513 sizing Methods 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 1
- 240000002853 Nelumbo nucifera Species 0.000 claims 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 63
- 230000000694 effects Effects 0.000 abstract description 53
- 230000006870 function Effects 0.000 abstract description 28
- 230000001737 promoting effect Effects 0.000 abstract description 23
- 230000005906 menstruation Effects 0.000 abstract description 20
- 210000002149 gonad Anatomy 0.000 abstract description 12
- 230000002611 ovarian Effects 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 238000011084 recovery Methods 0.000 abstract description 4
- 206010058359 Hypogonadism Diseases 0.000 abstract 1
- 238000000967 suction filtration Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 71
- 210000004369 blood Anatomy 0.000 description 70
- 210000004185 liver Anatomy 0.000 description 45
- 201000000736 Amenorrhea Diseases 0.000 description 38
- 206010001928 Amenorrhoea Diseases 0.000 description 38
- 231100000540 amenorrhea Toxicity 0.000 description 38
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 30
- 201000010099 disease Diseases 0.000 description 27
- 208000002193 Pain Diseases 0.000 description 23
- 230000036407 pain Effects 0.000 description 22
- 241001465754 Metazoa Species 0.000 description 19
- 230000008901 benefit Effects 0.000 description 17
- 230000017531 blood circulation Effects 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 230000001717 pathogenic effect Effects 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- 206010037660 Pyrexia Diseases 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 14
- 229940011871 estrogen Drugs 0.000 description 14
- 239000000262 estrogen Substances 0.000 description 14
- 231100000614 poison Toxicity 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 13
- 208000021267 infertility disease Diseases 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 230000004438 eyesight Effects 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 210000004291 uterus Anatomy 0.000 description 10
- 208000019255 Menstrual disease Diseases 0.000 description 9
- 238000004080 punching Methods 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 230000033228 biological regulation Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000002124 endocrine Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 230000001076 estrogenic effect Effects 0.000 description 7
- 238000007689 inspection Methods 0.000 description 7
- 239000002574 poison Substances 0.000 description 7
- 241000721047 Danaus plexippus Species 0.000 description 6
- 102000023108 LH Receptors Human genes 0.000 description 6
- 108010011942 LH Receptors Proteins 0.000 description 6
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 6
- 206010027304 Menopausal symptoms Diseases 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 230000035935 pregnancy Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 5
- 239000003390 Chinese drug Substances 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 208000009205 Tinnitus Diseases 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000004209 hair Anatomy 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 231100000886 tinnitus Toxicity 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010013954 Dysphoria Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 241000475481 Nebula Species 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000008217 follicular development Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000004914 menses Anatomy 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 230000027758 ovulation cycle Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 210000001215 vagina Anatomy 0.000 description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 208000019838 Blood disease Diseases 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 102000008175 FSH Receptors Human genes 0.000 description 3
- 108010060374 FSH Receptors Proteins 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000037656 Respiratory Sounds Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000003748 differential diagnosis Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 229960005309 estradiol Drugs 0.000 description 3
- 229930182833 estradiol Natural products 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000003163 gonadal steroid hormone Substances 0.000 description 3
- 208000014951 hematologic disease Diseases 0.000 description 3
- 208000018706 hematopoietic system disease Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000000554 physical therapy Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 238000011269 treatment regimen Methods 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 241001062009 Indigofera Species 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030247 Oestrogen deficiency Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000489 anti-atherogenic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 229940100691 oral capsule Drugs 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 229940023488 pill Drugs 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NULBHTHMVOCGOE-ZBCCAYPVSA-N 7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@H](OC=2C=C3C(C(C=C(O3)C=3C=CC(O)=CC=3)=O)=C(O)C=2)O1 NULBHTHMVOCGOE-ZBCCAYPVSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000026872 Addison Disease Diseases 0.000 description 1
- 206010001367 Adrenal insufficiency Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 208000004746 Atrophic Vaginitis Diseases 0.000 description 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241001161070 Calomela Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 244000013539 Cuscuta australis Species 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 241001609679 Cuscuta japonica Species 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 208000004483 Dyspareunia Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241001362411 Epimedium sagittatum Species 0.000 description 1
- 241001362415 Epimedium wushanense Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241001110058 Euphrasia pectinata Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 241000366676 Justicia pectoralis Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010071018 Urogenital atrophy Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 analgesia Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 208000009973 brain hypoxia - ischemia Diseases 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000008840 bushen tiaochong Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000009164 estrogen replacement therapy Methods 0.000 description 1
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- STKUCSFEBXPTAY-KCWGXYKVSA-N nuezhenoside Natural products COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(=CC)[C@@H]1CC(=O)OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O STKUCSFEBXPTAY-KCWGXYKVSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 1
- 229940063238 premarin Drugs 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method of a traditional Chinese medicinal composition for treating premature ovarian failure of women. The preparation method comprises the following steps: in a step c, combining a component 1 with a component 2, and then putting a composition into a decompression concentration tank; recovering ethanol under reduced pressure, and concentrating until the concentration of liquid medicine is 0.6g of crude drug/ml; performing suction filtration until the relative density of filtrate is 1.06 at 20DEG C; adsorbing the filtrate by using a macroporous resin absorption column with the volume of 10L, and then using deionized water or distilled water which is 10 times of resin column volume for eluting; subsequently using 95 percent ethanol which is 5 times of resin column volume for eluting; collecting ethanol eluant, and removing a solvent to obtain medicinal powder, drying and charging into capsules. The traditional Chinese medicine for invigorating kidney for regulating menstruation has the functions of delaying hypogonadism and promoting recovery of ovarian functions; meanwhile, the traditional Chinese medicine for invigorating kidney has a certain adjusting effect for functions of female gonad axis.
Description
Technical field
The present invention relates to, containing the medicinal preparation deriving from plant composition, treat women's liver-fire band particularly to one
Under Chinese medicine composition and preparation method thereof.
Background technology
Premature ovarian failure (POF) is the phenomenon of amenorrhea before referring to 40 years old that ovarian function failure is caused.Feature is primary
Or secondary amenorrhea raises with blood Gonadotropin Level and estrogen level reduces, and a series of low female with in various degree
Hormone symptom is such as: hectic fever hyperhidrosis, flush, hyposexuality etc..The average natural menopause age of women is 50~52 years old, menopause
Age also exists the difference of race and Area distribution, but its absolute value is more or less the same.Coulam etc. sum up oneself of 1858 example women
So amenorrhea situation, the POF incidence rate less than 40 years old is 1%, and the POF incidence rate less than 30 years old is 1 ‰.In primary amenorrhea, POF accounts for
10%~28%, in secondary amenorrhea, POF accounts for 4%~18%.Xu Ling etc. find that Beijing area women's POF incidence rate is 1.8%.By
This is visible, and POF is the most much.
Premature ovarian failure (POF) is with change in menstrual cycle characteristics, estrogen deficiency, the rising of FSH level, decrease in estrogen for clinical special
Point.Western medicine diagnose standard is to occur amenorrhea in more than at least 4 months before 40 years old, and has 2 times or above serum FSH > 40U/L (2
Secondary inspection intervals more than 1 month), estradiol level < 73.2pmol/L.Tcm diagnosis standard is cracked ends before 40 years old, and menstruation is dilute
Few, gradually to amenorrhea or menolipsis suddenly, warm sweating, hectic fever is flushing, dysphoria with feverish sensation in the chest palms and soles, dizziness and tinnitus, soreness of the waist and knees or metapedes with pain,
Urinate red dry stool, emaciated physique, vaginal dryness.B ultrasonic shows that uterus is less than normal or both sides ovary is less than normal, does not finds follicle or only monitors continuously
Seeing the most developable little follicle of only a few, blood serum E2 low SI, FSH is significantly raised, red tongue or have crackle, tongue few, thready pulse
Number or band string.
Premature ovarian failure accounts for the 1%~3.8% of women's total number of persons, is the commonly encountered diseases in gynecological endocrine field.Owing to this type of is suffered from
Person shows as early sending out or primary amenorrhea, estrogen are lowly caused perimenopausal symptom and infertile, therefore belong to traditional Chinese medical science amenorrhea, early send out absolutely
Warp, menopausal syndrome, the category such as infertile.Owing to suffering from a deficiency of the kidney, function senilism is appointed in punching, and the dyspoiesis of menses causes uterus vessels of the uterus (blood
Sea) hollow, depletion of blood can descend and menopause praecox."Fu Qingzhu works on obstetric" cloud: " the most disconnected through water, it appears that kidney water declines and dries up ".Because women is with blood
It is main, and " YIN often being in shortage, YANG often being in excess ", therefore treatment should focus on tonifying kidney and nourishing yin, promoting blood flow to regulate menstruation.In tonifying kidney and nourishing yin Fang Fang, Radix Rehmanniae Preparata is grown
Kidney yin, benefit marrow is monarch drug.Premature ovarian failure has obvious heterogeneity to clinical manifestation from the cause of disease to the course of disease, carry out correct
Etiological diagnosis, dialectical combines with differential diagnosis of diseases, takes corresponding treatment strategies, to improve healthy or to delay gonad old and feeble.
Modern study is thought, Bushen Tiaochong Chinese medicine has health invigorating, and regulation gonad axis and immunologic function, even delay gonad
Old and feeble effect.Clinic shows, the clinical practice of tonifying kidney and nourishing yin side safely, effectively, treats premature ovarian failure curative effect certainly, untoward reaction
Few, have certain effect in terms of protection, recovery ovarian function, its curative effect is equal to simple western medicine treatment, and toxic and side effects
Less, low price.
The most best therapeutic modality is the method using traditional Chinese medical science conditioning and treating.Chinese traditional treatment can effectively solve disease
Sick surface symptoms, can solve again the basic factor caused a disease thoroughly.Patient can also be the most suitable selection
Physiotherapy.But, patient it is noted that must not at will medication, to carry out under the guidance of expert.For physiotherapy, also
Limited, it is impossible to excessively, to be unfavorable for the state of an illness the most on the contrary, damage the health of patient.
Summary of the invention
The technical problem to be solved is, estrogen and progestogen replacement therapy is for young POF patient
Very important, i.e. can alleviate low estrogen symptom and Urogenital atrophy (preparing for giving ovum embryo transfer), again may be used
With prevention long term complication (osteoporosis, senile dementia etc.), the risk reduction 37% of colon cancer.But long-term HRT also has
Certain risk, such as carcinoma of endometrium and the generation of breast carcinoma.The traditional Chinese medical science is particular about and is suited the remedy to the case, and individual variation is obvious, be expert
Guidance under carry out.For physiotherapy, the most limited, it is impossible to excessively, to be unfavorable for the state of an illness the most on the contrary, damage the strong of patient
Health.The present invention combines clinical experience for many years on the basis of traditional medicine, uses modern processing method meticulously to develop.This
Bright each effective ingredient scientific compatibility to raw material medicine, focus of going directly, and instant effect, side effect be little, can efficient solution except patient
Misery, reach the purpose of dispelling disease.
For solving above-mentioned technical barrier, the present invention provides a kind of Chinese medicine composition treating women's ovary senilism, by taking orally
Medicine and external used medicine composition, described endo-medicine can include the crude drug of following weight portion: Radix Paeoniae Rubra 10~20 parts, Caulis Spatholobi
10~20 parts, Fructus Corni 10~20 parts, Herba Leonuri 10~20 parts, Radix Bupleuri 10~20 parts, Radix Arnebiae (Radix Lithospermi) 10~20 parts, Radix Rehmanniae Preparata 10~20
Part, Fructus Ligustri Lucidi 10~20 parts, Herba Ecliptae 10~20 parts, Fructus Schisandrae Chinensis 10~20 parts, Fructus Rubi 10~20 parts, Semen Cuscutae 10~20
Part, Herba Epimedii 10~20 parts, Cortex Moutan 10~20 parts, Radix Puerariae 10~20 parts;
Described external used medicine can include the crude drug of following parts by weight: Radix Arnebiae (Radix Lithospermi) 10~20 parts, Radix Sophorae Flavescentis 10~20 parts, Serpentis
Machine tool 10~20 parts, Rhizoma Smilacis Glabrae 10~20 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10~20 parts, Folium Artemisiae Argyi 10~20 parts, Indigo Naturalis 10~20 parts, Spica Prunellae 10~
20 parts, Borneolum Syntheticum 10~20 parts, Herba Euphrasiae Regelii 10~20 parts.
The Chinese medicine composition of described treatment women's ovary senilism, its described endo-medicine can also include following weight portion
Crude drug: Radix Paeoniae Rubra 10~15 parts, Caulis Spatholobi 10~15 parts, Fructus Corni 10~15 parts, Herba Leonuri 10~15 parts, Radix Bupleuri 10~15
Part, Radix Arnebiae (Radix Lithospermi) 10~15 parts, Radix Rehmanniae Preparata 10~15 parts, Fructus Ligustri Lucidi 10~15 parts, Herba Ecliptae 10~15 parts, Fructus Schisandrae Chinensis 10~20 parts, cover
Basin 10~20 parts, Semen Cuscutae 10~20 parts, Herba Epimedii 10~20 parts, Cortex Moutan 10~20 parts, Radix Puerariae 10~20 parts;
Described external used medicine can also include the crude drug of following parts by weight: Radix Arnebiae (Radix Lithospermi) 10~15 parts, Radix Sophorae Flavescentis 10~15 parts,
Fructus Cnidii 10~15 parts, Rhizoma Smilacis Glabrae 10~15 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10~15 parts, Folium Artemisiae Argyi 10~20 parts, Indigo Naturalis 10~20 parts, Spica Prunellae 10
~20 parts, Borneolum Syntheticum 10~20 parts, Herba Euphrasiae Regelii 10~20 parts.
The Chinese medicine composition of described treatment women's ovary senilism, its described endo-medicine can also include following weight portion
Crude drug: Radix Paeoniae Rubra 10~20 parts, Caulis Spatholobi 10~20 parts, Fructus Corni 10~20 parts, Herba Leonuri 10~20 parts, Radix Bupleuri 10~20
Part, Radix Arnebiae (Radix Lithospermi) 10~20 parts, Radix Rehmanniae Preparata 10~20 parts, Fructus Ligustri Lucidi 10~20 parts, Herba Ecliptae 10~20 parts, Fructus Schisandrae Chinensis 10~15 parts, cover
Basin 10~15 parts, Semen Cuscutae 10~15 parts, Herba Epimedii 10~15 parts, Cortex Moutan 10~15 parts, Radix Puerariae 10~15 parts;
Described external used medicine can also include the crude drug of following parts by weight: Radix Arnebiae (Radix Lithospermi) 10~20 parts, Radix Sophorae Flavescentis 10~20 parts,
Fructus Cnidii 10~20 parts, Rhizoma Smilacis Glabrae 10~20 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10~20 parts, Folium Artemisiae Argyi 10~15 parts, Indigo Naturalis 10~15 parts, Spica Prunellae 10
~15 parts, Borneolum Syntheticum 10~15 parts, Herba Euphrasiae Regelii 10~15 parts.
For solving above-mentioned technical problem, the present invention also provides for the preparation of a kind of Chinese medicine composition treating women's ovary senilism
Method, its described endo-medicine is that the preparation process of capsule includes:
A, take crude drug put in ethanol soak, heat extract 2 times, for component 1;
B, medicinal residues extracting in water 2 times, thickening filtration, for component 2;
C, by above two component merge, concentrate, be dried to powder load capsule.
In described step a, can take in the ethanol of crude drug addition 5-10 times amount and soak 1-2 hour, heating extraction 2 times,
1-2 hour every time, united extraction liquid, remove supernatant after standing, then 100-120 mesh filters, then through the molecular weight that dams be 5000-
The ultrafiltration post ultrafiltration of 10000, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, the extractum of 1.36, stand for standby use, become component
1。
In described step b, the medicinal residues that can take the crude drug that above-mentioned ethanol extraction is crossed add 10 times amount water, heating and refluxing extraction
2 times, each 1~2 hour, 2 extracting solution are merged and stands, become component 2.
In described step c, component 1 and the merging of component 2 can be then placed in concentrating under reduced pressure tank, recovered under reduced pressure second
Alcohol, being concentrated into liquor strength is 0.6g crude drug/mL, when the relative density of sucking filtration to filtrate is 20 DEG C 1.06;Above-mentioned filtrate is through body
Amass after the macroporous adsorptive resins for 10L adsorbs, with deionized water or the distilled water eluting of 10 times of resin column volumes, then with 5 times
95% ethanol elution of resin column volume, collects ethanol elution, removes solvent, obtains medicated powder and load capsule after drying.
For solving above-mentioned technical problem, the present invention also provides for the preparation of a kind of Chinese medicine composition treating women's ovary senilism
Method, described external used medicine is that the preparation process of suppository includes:
A. take the Pseudobulbus Bletillae (Rhizoma Bletillae), Indigo Naturalis, the Borneolum Syntheticum way of distillation are vaporized into crystallization, pulverize dusting cover stand-by, as component 1;
B. remaining raw material ethanol is extracted, concentrate, as component 2;
C. adding substrate after component 1, component 2 being mixed to be in harmonious proportion, suppository, sterilization pack are made in sizing.
In described step a, crystal can be obtained, so first by the crude drug Pseudobulbus Bletillae (Rhizoma Bletillae), Indigo Naturalis, the distillation of Borneolum Syntheticum steam method
Rear pulverizing, crosses 100-120 mesh sieve, standby as component 1;In described step b, again remaining crude drug can be shredded, be soaked
Bubble has been placed in lid stainless steel cask, adds 70% ethanol, and quality is coarse grained 0.8-1 times, stirs, moistening airtight placement
More than 1 hour, make fully to expand;Filter plate gauze bag bottom percolator is wrapped up after paving again by the medicine sample after moistening expansion
Product are mixed pine and are done to dissipate, and then contain powder with rustless steel spoon, load percolator uniformly, fill 10-12 cm thick, even by T-bar pressure, then press
Aforesaid operations, loading in layer, suitably pressurize, medicated powder loads 2/3 eminence that must not exceed percolator;Medicated powder face upper cover is not
Rust steel orifice plate fastens, and opens the baiting valve below percolator, and puts a container, is then slowly added into 70% ethanol;To be discharged
Air between medicated powder powder, and have ethanol to flow out about about 20L, close baiting valve, cover cylinder of filtering, dipping 24 hours, then
Opening baiting valve and carry out percolation, control percolation speed and be generally 1000g medical material outflow per minute 2~3ml, filtrate puts into liquid container
In, and pour ethanol during emptying into liquid container;Percolate is merged and stands, as component 2;Component 1 component 2 mixes patent medicine
Cream;Choose 50 DEG C~60 DEG C heating and melting of substrate, add ointment cooling and shaping obtained above and make class warhead shape suppository, ultraviolet
Line is killed virus.
The preparation method of described treatment women's ovary senilism external suppository, its substrate used by described suppository can be selected from:
One or more in semi-synthetic fatty acid glyceride, poloxamer, Polyethylene Glycol, lanoline;Described substrate is at temperature 50 C
~heating and melting under the conditions of 60 DEG C, adding the medicine mastic that described preparation method prepares, stirring in water bath is uniform, is mixed into thickness
Liquid, is poured in plastic shape-forming pipe, inserts tampon, and cooling and shaping makes bullet-shaped suppository;Described tampon be afterbody with
The tampon of cotton thread..
The present invention uses stype and tampon integrated technique, compensate for the deficiency of ordinary suppository, and ordinary suppository can not effectively send
Reach the depths of vagina.Due to the self purification of vagina, in the presence of having foreign body, liquid secretion can be increased, at short notice will
Medicine is got rid of external, had both reduced curative effect, and had extended again the course for the treatment of, and increase expense pollutes again underwear.And the present invention overcomes this
Technical barrier, the suppository made can give full play to curative effect of medication, has safety good, the advantage that feasibility is good, focus of going directly,
Reach the purpose that gets rid of illness.
Tonifying kidney and nourishing yin of the present invention, promoting blood flow to regulate menstruation.Radix Rehmanniae Preparata nourishing kidney-yin in tonifying kidney and nourishing yin side, benefit marrow is monarch drug.Fructus Corni, what
The Radix Polygoni Multiflori, Semen Cuscutae liver and kidney tonifying, support essence and blood.Radix Arnebiae (Radix Lithospermi), Radix Paeoniae Rubra activating blood circulation to dissipate blood stasis, promoting the circulation of blood nourishing the liver blood, adjust punching to appoint.Herba Epimedii tonification liver
Kidney.Fructus Ligustri Lucidi, Herba Ecliptae are ERZHI WAN, effect tonifying kidney and nourishing liver benefit essence.Radix Bupleuri nourishing YIN and clearing away heat pathogenic fire purging.Radix Puerariae clearing away heat and promoting production of body fluid, according to existing
For pharmacological research Radix Puerariae, there is estrogen-like effects, for women's reproductive endocrine, there is regulation effect.All medicines share plays benefit altogether
Kidney nourishing yin and activating blood, takes good care of punching and appoints effect.Invigorating kidney for regulating menstruation Chinese medicine has delay adenasthenia effect, has again promotion ovarian function
Restitution, kidney-nourishing tcm drug has certain regulation effect to female gonad s function simultaneously, finds to mend by animal experiment study
Renal drug has promotion ovary LH/HCG receptor to increase phenomenon.Chinese medicine there may also be promote fsh receptor produce effect, nourishing the liver and kidney,
Benefit intensive culture blood Chinese medicine has the effect promoting follicular development.
Detailed description of the invention
Premature ovarian failure (POF) is with change in menstrual cycle characteristics, estrogen deficiency, the rising of FSH level, decrease in estrogen for clinical special
Point.Western medicine diagnose standard is to occur amenorrhea in more than at least 4 months before 40 years old, and has 2 times or above serum FSH > 40U/L (2
Secondary inspection intervals more than 1 month), estradiol level < 73.2pmol/L.Tcm diagnosis standard is cracked ends before 40 years old, and menstruation is dilute
Few, gradually to amenorrhea or menolipsis suddenly, warm sweating, hectic fever is flushing, dysphoria with feverish sensation in the chest palms and soles, dizziness and tinnitus, soreness of the waist and knees or metapedes with pain,
Urinate red dry stool, emaciated physique, vaginal dryness.B ultrasonic shows that uterus is less than normal or both sides ovary is less than normal, does not finds follicle or only monitors continuously
Seeing the most developable little follicle of only a few, blood serum E2 low SI, FSH is significantly raised, red tongue or have crackle, tongue few, thready pulse
Number or band string.
Premature ovarian failure accounts for the 1%~3.8% of women's total number of persons, is the commonly encountered diseases in gynecological endocrine field.Owing to this type of is suffered from
Person shows as early sending out or primary amenorrhea, estrogen are lowly caused perimenopausal symptom and infertile, therefore belong to traditional Chinese medical science amenorrhea, early send out absolutely
Warp, menopausal syndrome, the category such as infertile.Owing to suffering from a deficiency of the kidney, function senilism is appointed in punching, and the dyspoiesis of menses causes uterus vessels of the uterus (blood
Sea) hollow, depletion of blood can descend and menopause praecox."Fu Qingzhu works on obstetric" cloud: " the most disconnected through water, it appears that kidney water declines and dries up ".Because women is with blood
It is main, and " YIN often being in shortage, YANG often being in excess ", therefore treatment should focus on tonifying kidney and nourishing yin, promoting blood flow to regulate menstruation.In tonifying kidney and nourishing yin Fang Fang, Radix Rehmanniae Preparata is grown
Kidney yin, benefit marrow is monarch drug.Premature ovarian failure has obvious heterogeneity to clinical manifestation from the cause of disease to the course of disease, carry out correct
Etiological diagnosis, dialectical combines with differential diagnosis of diseases, takes corresponding treatment strategies, to improve healthy or to delay gonad old and feeble.
1. amenorrhea is divided into primary amenorrhea and secondary amenorrhea, and secondary amenorrhea occurred before 40 years old.By the POF to large sample
The investigation of patient does not has the tendency of distinctive irregular menstruation before finding amenorrhea.Somebody is unexpected after the menstruation of rule
Amenorrhea, has plenty of and stops amenorrhea after contraceptive or childbirth, the disorder then showing as menstrual cycle and menstrual period before amenorrhea having.
The most infertile some patients finds premature ovarian failure because of infertile medical.Infertile is that chain reaction in patients with premature ovarian is medical and worried
Main cause.There are fertility and infertility, so suggestion has premature ovarian failure family history person should plan pregnancy as early as possible.
3. low estrogen symptom primary amenorrhea person low estrogen symptom (hectic fever and/or dyspareunia etc.) is rare
(22.2%), also mostly using estrogen replacement therapy relevant with the past if had, secondary amenorrhea person's low estrogen symptom is common
(85.6%).This is that withdrawn the theory caused by estrogen consistent with low estrogen symptom.These low estrogen symptoms are also wrapped
Include atrophic vaginitis and the atrophic urethritis such as frequent micturition, dysurea.
4. the performance of the autoimmune disease occurred together such as Addison disease, thyroid disease, diabetes, lupus erythematosus, class
Rheumatic arthritis, vitiligo and crohn etc..Additionally also has the concealment symptom of adrenal insufficiency, such as subtracting of recent body weight
Gently, loss of appetite, indefinite abdominal pain, weak, cutaneous pigmentation increase the weight of and addicted to salt.
Tonifying kidney and nourishing yin of the present invention, promoting blood flow to regulate menstruation.Radix Rehmanniae Preparata nourishing kidney-yin in tonifying kidney and nourishing yin side, benefit marrow is monarch drug.Fructus Corni, what
The Radix Polygoni Multiflori, Semen Cuscutae liver and kidney tonifying, support essence and blood.Radix Arnebiae (Radix Lithospermi), Radix Paeoniae Rubra activating blood circulation to dissipate blood stasis, promoting the circulation of blood nourishing the liver blood, adjust punching to appoint.Herba Epimedii tonification liver
Kidney.Fructus Ligustri Lucidi, Herba Ecliptae are ERZHI WAN, effect tonifying kidney and nourishing liver benefit essence.Radix Bupleuri nourishing YIN and clearing away heat pathogenic fire purging.Radix Puerariae clearing away heat and promoting production of body fluid, according to existing
For pharmacological research Radix Puerariae, there is estrogen-like effects, for women's reproductive endocrine, there is regulation effect.All medicines share plays benefit altogether
Kidney nourishing yin and activating blood, takes good care of punching and appoints effect.Invigorating kidney for regulating menstruation Chinese medicine has delay adenasthenia effect, has again promotion ovarian function
Restitution, kidney-nourishing tcm drug has certain regulation effect to female gonad s function simultaneously, finds to mend by animal experiment study
Renal drug has promotion ovary LH/HCG receptor to increase phenomenon.Chinese medicine there may also be promote fsh receptor produce effect, nourishing the liver and kidney,
Benefit intensive culture blood Chinese medicine has the effect promoting follicular development.
Caulis Spatholobi is bitter, sweet, temperature.Return liver, kidney channel.Cure mainly: relaxing muscles and tendons to promote blood circulation;Nourishing blood for regulating menstruation.Main numb hand and foot;Quadriplegia;
Rheumatic arthralgia;Women has through uncomfortable;Dysmenorrhea;Amenorrhea.Function: enrich blood, invigorates blood circulation, dredging collateral.For menoxenia, blood deficiency and yellow complexion, fiber crops
Wood paralysis, rheumatic arthralgia." decoction pieces is newly joined ": remove blood stasis, tissue regeneration promoting blood, fluent passages through which vital energy circulates.Control summer filthy infection, wind arthralgia due to stagnation of blood disease." in modern practicality
Medicine ": for the hematonic of robustness, it is adaptable to anemicus neural paralysis disease, such as limbs and soreness of waist and knee joint, apathy etc..Again
For menoxenia, menstruation apolipsis etc., there is the effect of invigorating blood circulation analgesia.
Fructus Corni, cures mainly pathogen cold and heat under the heart, warming middle-JIAO, by cold temperature numbness, goes three worms, and clothes have been made light of one's life by commiting suicide for a long time, and reinforcing YIN-essence benefit is smart, pacify five
The merit of nine orifices, only dribbling urination dirty, logical;Take improving eyesight, strength for a long time all the year round.Fructus Corni, has another name called Fructus Corni, medicine Fructus Jujubae, real Fructus Jujubae, Fructus Jujubae
Skin, meat Fructus Jujubae etc., commonly use rare Chinese medicine for China, and applicating history is long.It is gentle with its benefit power, tonifying YANG and do not help fire, YIN nourishing
And oiliness diaphragm, convergence and do not stay the special efficacies such as heresy to be liked use by successive dynasties medical science.Zhang Zhongjing has been formulated " golden deficient with Fructus Corni for monarch
Shenqi pill ".According to chemical analysis, Fructus Corni contains the stronger cornin of physiologically active, tartaric acid, gallic acid, malic acid, tree
The effective ingredient such as ester, tannin and multivitamin, have enhancing immunity, antiinflammatory, the pharmacological action such as antibacterial, are normal in tcm clinical practice
Herba indigoferae Pseudotinctoriae.
Radix Bupleuri meridian distribution of property and flavor: cold nature, bitter in the mouth, pungent, return Liver Channel, gallbladder meridian, tool depressed liver-energy dispersing and function of gallbladder promoting, dredge gas resolving depression, dissipate the merit of fire
Effect.Function: expelling pathogenic factors from the exterior expels the heat-evil, dispersing the stagnated live-QI to relieve the stagnation of QI, rise and lift yang-energy.Cure mainly: the heating that cures cold, cold and heat deficient fever.Children's's varioliform exanthema waste heat,
Emaciation and sallow complexion abdominal part expands, [3] malaria, stagnation of QI due to depression of the liver, sternal rib pain, and proctoptosis, uterus comes off, menoxenia." book on Chinese herbal medicine is just ": "
Radix Bupleuri, cool scattered with it with this person, the heat of suppressing the hyperactive liver.It is cool in nature, therefore solves alternate attack of chill and fever, flesh table hectic fever, and liver and gall fire is scorching, and chest and hypochondrium is tied,
Double skin infection of controlling, blood room is heated;Its property dissipates, therefore main typhoid fever pathogenic heat do not solve, epidemic febrile disease intenseness of heat, SHAO YANG headache, Liver Channel melancholia.
Fructus Ligustri Lucidi, sweet-bitter flavor, cool in nature, return Liver and kidney warp, there is nourishing the liver and kidney, merit that tonifying YIN nourishes blood.Modern medicine study is demonstrate,proved
Bright, Fructus Ligustri Lucidi includes ursolic acid, mannitol, glucose, fatty oil etc., has heart tonifying, diuresis and hepatoprotective effect, can make because chemotherapy is drawn
The leukopenia quantity risen raises, and staphylococcus aureus, escherichia coli are had inhibitory action.Containing neat pier in Fructus Ligustri Lucidi
The acid of fruit acid Fructus Ligustri Lucidi, nuezhenoside, ursolic acid, stearic acid, oleic acid, mannitol, betulin, phospholipid and saccharide such as Fructus Ligustri Lucidi are many
Sugar, arabinose, glucose etc., possibly together with 15 kinds of aminoacid, 11 kinds of trace element and volatile oil etc..Research thinks that Fructus Ligustri Lucidi has
Blood sugar lowering and blood fat reducing also have study of anti-atherogenic effect, the most antibacterial, antivirus action, and Fructus Ligustri Lucidi decoct is to golden yellow Portugal
Grape coccus, shigella flexneri, Bacillus typhi, bacillus pyocyaneus and escherichia coli all have inhibitory action.Type B adenovirus is had medium
Degree inhibitory action.Leukocyte increasing: Fructus Ligustri Lucidi and component preparation thereof all have certain impact to hemocyte, it is to white caused by chemotherapy
Cell declines rising effect.Compound recipe containing Fructus Ligustri Lucidi also has effect in increasing leukocyte.Anti thrombotic action: oleanolic acid can accelerate blood
The mobility of platelet cell, reduces the collision between platelet, is allowed to be difficult to adhesion and gathering, is less susceptible to sink in tunica intima
Long-pending, slow down or prevent thrombosis, the deposition of lipid inner membrance can be reduced again, the thrombotic disease for preventing and treating old people provides portion
Divide experimental basis.Defying age improves immunity: Fructus Ligustri Lucidi decoct can make mouse immune organ thymus, spleen weight increase;Substantially
Improving mice serum hemolytic antibody activity, the impact that mouse spleen lymphocyte produces interleukin-2 has two-ways regulation work
With.Fructus Ligustri Lucidi has significant immunological enhancement, removes free radical thus defying age.Application Fructus Ligustri Lucidi preventing and treating: cardiovascular disease
Disease, coronary heart disease, hyperlipemia, diabetes, thrombocytopenia, leukopenia, chronic nephritis, chronic bronchitis, stupid
Solidity insomnia, Chronic Benzene Poisoning, tumor, malnutrition, immunologic hypofunction disease, seborrheic dermatitis
Cortex Moutan, Chinese medicine name.It is dried root bark for ranunculaceae peony.Originate in the ground such as Anhui, Shandong.Autumn excavates root,
Remove radicula, strip root bark, dry.Life is used or is fried and uses.Compendium of Material Medica: " nourishing YIN to lower pathogenic fire solves speckle poison, throat, diuresis blood
Stagnant.Descendant is specially to control fire mutually with yellow tiller, does not knows that the merit of Cortex Moutan more wins also.Red colored person profit, the person of spending in vain mends, and people the most seldom realizes, and preferably distinguishes
It." modern study, contained paeonol and glucosides constituents in addition thereof all have antiinflammatory action;The methanolic extract of Cortex Moutan has
Suppression Platelet;Paeonol has the central inhibitory actions such as calmness, cooling, antipyretic, analgesia, spasmolytic and anti-atherogenic hard
Change, diuresis, antiulcer etc. act on.
Radix Salviae Miltiorrhizae is bitter, is slightly cold.GUIXIN, Liver Channel.Stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness.For menoxenia, amenorrhea pain
Warp, lump in the abdomen, chest and abdomen twinge, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia.For costa sternales hypochondriac pain, rheumatic arthralgia, lump in the abdomen is tied
Block, skin infection swells and ache, and tumbling down is grieved, menoxenia, amenorrhea dysmenorrhea, puerperal stasis of blood pain etc..Treatment costa sternales pain, lump in the abdomen caking, and
Menoxenia, amenorrhea dysmenorrhoea have good effect." detailed outline " carries: Radix Salviae Miltiorrhizae, and by " the sensible opinion of married woman " cloud, SIWU TANG is controlled gynecopathy, paid no attention to
Antenatal puerperal, how many through water, the most generally applicable, only taste Radix Salviae Miltiorrhizae dissipates, and cures mainly same.Lid Radix Salviae Miltiorrhizae can break stagnated blood, mends fresh blood, peace
Green tire, fall stillborn fetus, only metrorrhagia dysentery, regulating menstruation arteries and veins.
Fructus Rubi plant can be used as medicine, and has multi-medicament to be worth, and its fruit has the effect of kidney invigorating and YANG supporting.Raspberry seed oil belongs to not
Satisfied fatty acid, can promote that the severe that of prostatic secretions covers.Effect: the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination, improving eyesight.With rat, the vagina of rabbit
Treatment index is made in smear and inner membrance section, and Fructus Rubi seemingly has estrogen-like effects.Bacteriostasis 100% decoct flat board burrows
Method, has inhibitory action to staphylococcus, also has inhibitory action to vibrio cholera.Estrogen-like effects rat, the vaginal smear of rabbit
And the index such as inner membrance section shows, Fructus Rubi seemingly has estrogen-like effects.
Herba Leonuri acrid in the mouth is bitter, cool.Invigorate blood circulation, silt of dispelling, regulating menstruation, disappear water.Treatment menoxenia, vaginal bleeding during pregnancy difficult labour, afterbirth is not
Under, puerperal blood faints, abdominal pain due to blood stasis, metrorrhagia and metrostaxis, hematuria, rushes down blood, carbuncle skin infection.Herba Leonuri alkalescence subcutaneous injection has CNS inhibition
Effect, MLD is 0.4-0.6g/kg.Intravenous rabbit injection leonurine 1mg/kg, it is seen that urine volume dramatically increases.Leonurine is relatively
Sanguis Leporis seu oryctolagi suspension generation haemolysis can be made during high concentration.Leonurine infusion tube dilution method 1: 13-1: 10, to Lan Shi perhaps
Trichobacteria, Pilus Caprae seu Ovis sample sporidiole bacteria, epidermophyton rubrum, starlike nocadia all have inhibitory action.Herba Leonuri decoct sheet paper
Sheet method, has inhibitory action to escherichia coli, dysentery bacterium.Herba Leonuri can remove silt tissue regeneration promoting, and promoting blood flow to regulate menstruation, containing selenium, manganese
Etc. various trace elements, can antioxidation, anti-aging, there is pretty good beneficial face beauty treatment, anti-aging effect.
Radix Puerariae, Chinese medicine name.For the dry root of legume pueraria lobata, practise and claim Herba Gelsemii Elegantis.Autumn, season in winter two excavate, and take advantage of fresh-cut and become thickness
Sheet or fritter;It is dried.Sweet, pungent, cool.There are expelling pathogenic factors from muscles for reducing heat, rash, promoting the production of body fluid to quench thirst, the merit of yang invigorating antidiarrheal.It is usually used in exterior syndrome heating,
Stiff nape and back, measles without adequate eruption, calentura is thirsty, and the deficiency of YIN is quenched one's thirst, diarrhea of heat type hematodiarrhoea, diarrhea due to hypofunction of the spleen.
Semen Cuscutae: Cuscuta chinensis is dicotyledon scammonia section plant Semen Cuscutae, Cuscuta australis, cuscuta japonica Choisy etc.
Seed, can the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, effect of solid tire stopping leak.Nourishing the liver and kidney, controlling nocturnal emission with astringent drugs reducing urination, antiabortive, improving eyesight, antidiarrheal.For
Impotence and seminal emission, dripping urination, enuresis frequent micturition, soreness of the waist and knees, blurred vision tinnitus, vaginal bleeding due to deficiency of the kidney during pregnancy, frequent fetal movement, spleen kidney vaginal bleeding during pregnancy, fetal movement
Uneasy, spleen is suffered from a deficiency of the kidney and is rushed down;Externally treating leucoderma.Former medicine sieve is removed spare, picks decontamination, dry.
Radix Rehmanniae Preparata is the tuber of scrophulariaceae rehmannia glutinosa plant (formal name used at school: Rehmannia glutinosa), has another name called Radix Rehmanniae Preparata or volt
Ground, the processed process of preparing Chinese medicine forms.Generally with wine, Fructus Amomi, Pericarpium Citri Reticulatae for adjuvant through repeatedly steaming solarization, glossy to inside and outside darkish complexion, quality is soft
Sticky.Section use, or parch to black use.Radix Rehmanniae Preparata has another name called Radix Rehmanniae Preparata or throws oneself on the ground, and belongs to goatweed, is a kind of first-class Chinese crude drug, has
YIN nourishing of enriching blood effect, can be used for blood deficiency and yellow complexion, dizziness, palpitation and insomnia, menoxenia, the disease such as metrorrhagia, also can be used for deficiency of kidney yin
Hectic fever hectic fever due to YIN-deficiency, night sweat, pass out semen, the disease such as quench one's thirst, be one of deficiency syndrome class nonprescription drugs medicine LIUWEI DIHUANG WAN main component.
Fructus Schisandrae Chinensis is magnoliaceae schisandra Schisandra chinensis (Turcz.) Baill. or Central China five tastes
The dry mature fruit of sub-Schisandra sphenanthera Rehd.et Wils..The former practises title " Radix Schisandrae Bicoloris ", the latter
Practise and claim " Fructus Schisandrae Sphenantherae ".Pluck during fruit maturation in autumn, dry after drying or steaming, remove carpopodium and impurity." the Xin Xiuben such as Tang
Grass " carry " the sweet acid of five tastes skin and flesh, arduous in core, have saline taste ", therefore have the name of Fructus Schisandrae Chinensis.Fructus Schisandrae Chinensis is divided into two kinds of south, north.Ancient doctor
Book claim it, profound and, meeting and, be listed in the top grade Chinese medicine in Sheng Nong's herbal classic the earliest, can the power of strengthening by means of tonics, medical value is high,
There is the effect of building body, share treatment insomnia with fine jade treasure Ganoderma.
Herba Ecliptae grass is the conventional liver-nourishing kidney-boosting of the traditional Chinese medical science, cooling blood for hemostasis medicine.To the Light-headedness caused by the hepatic and renal YIN deficiency, tooth
Loose compact, aching pain in waist and back, all diseases of flaccidity and weakness of the lower limbs and caused by heat in blood multiple go out blood disorder have good efficacy.Herba Ecliptae contains volatilization
The chemical compositions such as oil, tannin, Saponin, Herba Ecliptae element and vitamin A.Animal experiment has haemostatic effect, and in vitro tests is to golden yellow
Staphylococcus has inhibitory action.
Herba Epimedii is the multiple Herba Epimedii such as Berberidaceae plant Herba Epimedii, Epimedium sagittatum, Epimedium wushanense, Herba Epimedii
Stem and leaf.Taste is returned through acrid, sweet, warm.Liver, kidney channel is returned to cure mainly function: kidney-replenishing, bone and muscle strengthening, wind-damp dispelling.Herba Epimedii has and prolongs
Slow old and feeble, blood pressure lowering, blood sugar lowering, blood fat reducing.Improve cerebral hypoxia ischemia, reduce blood viscosity, suppression ex vivo thrombosis, stimulation
The synthesis of bone marrow DNA, increase peripheral blood leucocyte and the quantity of marrow hemopoietic stem cells, improve immunity, promote bone growth,
Pre-preventing bone rarefaction, antiinflammatory, antiviral, antitumor, the side effect of antagonism cancer therapy drug.
Chinese medicine Radix Polygoni Multiflori have Radix Polygoni Multiflori and Radix Polygoni Multiflori Preparata point, direct slicing is used as medicine for Radix Polygoni Multiflori, after mixing steaming with Semen sojae atricolor liquor
Dry and be used as medicine for Radix Polygoni Multiflori Preparata.The function of the two is different: the removing toxic substances of Radix Polygoni Multiflori function, eliminating carbuncle, loosening bowel to relieve constipation, is usually used in treating scrofula
Scrofula carbuncle sore, rubella pruritus, dryness of the intestine constipation;Radix Polygoni Multiflori Preparata function invigorating the liver and kidney, benefiting essence-blood, crow beard and hair, bone and muscle strengthening, for blood deficiency and yellow complexion,
Vertigo and tinnitus, early whitening of beard and hair, soreness of the waist and knees, numb limbs and tense tendons, bleeding not during menses, chronic malaria body are empty.Radix Polygoni Multiflori Preparata of the present invention
It it is the good merchantable brand of invigrating kidney.
Radix Paeoniae Rubra, Chinese medicine name.For ranunculaceae plant Radix Paeoniae Rubra or the dry root of river Radix Paeoniae Rubra.Spring, season in autumn two excavate, removing rhizome,
Fibrous root and silt, dry.Hardship, is slightly cold.Return Liver Channel.There is clearing away heat and cooling blood, effect of blood circulation promoting and blood stasis dispelling.Radix Paeoniae Rubra is in famous wild tunnel
Medical material,
External:
Rhizoma Smilacis Glabrae is sweet light, flat.Gui Jing: Liver Channel;Stomach warp;Spleen channel.Function: removing toxic substances, dehumidifying, profit joint.Cure mainly: control syphilis,
Stranguria with turbid discharge, muscles and bones spasm and pain, tinea pedis, treat furuncle, carbuncle, scrofula, the limbs contracture caused by syphilis and mercurialism, bones and muscles pain." book on Chinese herbal medicine
Justice ": Rhizoma Smilacis Glabrae, dampness removing reduces phlegm and internal heat, and can enter network, searches to pick and damp and hot accumulates poison.It solves d hydrargyrum, Calomelas poison person, and that are received on poison with ascending
OK, and this leads as business to ooze under profit, therefore specially controls Fructus Myricae rubrae skin infection, gos deep into hundred networks, and arthralgia is the most rotten, and poison fire is up again, pharynx
Laryngalgia is burst, and all dislike disease.
Fructus Cnidii is pungent, bitter, temperature;Slightly poisonous.Return kidney channel.Cure mainly warming the kidney to invigorate YANG, dampness, dispel the wind, parasite killing.For sexual impotence,
Cold womb, cold-damp leukorrhagia, arthralgia chiefly caused by damp pathogen lumbago;External treatment vulval eczema, married woman's pudendal pruritus;Trichomonal vaginitis, is gynecological external use good medicine." this
Grass is through dredging " carry: Fructus Cnidii, bitter in the mouth is put down;" not Lu " be pungent sweet nontoxic;Modern its abnormal smells from the patient in detail, when warm-dryness syndrome of must holding concurrently, sun is also.Therefore housewife people is cloudy
In swell and ache, man's impotence pruritus due to damp pathogen, eliminating impediment gas, profit joint, malignant boil." not Lu " warming the middle warmer and descending qi, makes married woman's clothes heat, and man is cloudy strong,
Make us there is son.Lid can dehumidify with tongue, temperature energy cold expelling, the pungent kidney that can moisten, sweet energy strengthening the spleen, therefore can be given birth to except all deficiency and coldness of married woman man are wet
Sick.Cold-damp was both removed, then disease is gone, performance Yiyang, thus can disease, and have tonification also.
Radix Sophorae Flavescentis is bitter, cold.GUIXIN, liver, stomach, large intestine, bladder are through heat clearing and damp drying, parasite killing, diuresis.For hematodiarrhoea, have blood in stool, yellow
Subcutaneous ulcer urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies leprosy;External treatment colpitis mycotica, Chang Yuhuang
Cypress is used in combination, and is to treat colpitic external use gynaecological good medicine.
Folium Artemisiae Argyi is pungent, bitter, temperature, nontoxic;Return liver,spleen,kidney warp.Dispersing cold for relieving pain, warming the meridian for stopping bleeding.For few abdomen cold type of pain, through trembling with fear not
Adjust, cold womb is infertile, spit blood, epistaxis, metrorrhagia through many, gestation hemorrhage;External treatment skin pruritus, decortication.Regulate the flow of vital energy blood, by cold-damp;Warming the meridian,
Hemostasis, antiabortive.Control trusted subordinate's cold type of pain, convulsion of having loose bowels, chronic dysentery, tell nosebleed, hematochezia, menoxenia, metrorrhagia, leukorrhagia, frequent fetal movement, carbuncle
Infections, scabies." not Lu ": main moxibustion all kinds of diseases and ailments.Can decoct, only dysentery, spit blood, hideing skin ulcer in bottom, married woman leaks blood.Li Yin gas, granulation promoting meat, ward off
Wind and cold, makes people have son.TAO Hong-Jing: smash leaf with moxibustion all kinds of diseases and ailments, the most only blood trouble.
Indigo Naturalis nature and flavor: salty, cold.Gui Jing: enter Liver Channel, lung meridian, stomach warp.Function: heat clearing away, blood cooling and ecchymoses removing, removing toxic substances, liver heat removing is rushed down
Fire, arresting convulsion.Curing mainly: control epidemic febrile disease intenseness of heat, macule, spit blood, spit blood, pediatric epilepsy scared, skin ulcer swells, erysipelas, snake bite and insect sting." book on Chinese herbal medicine warp
Dredge ": " Indigo Naturalis, detoxify heat extraction, Gu its chief, more ancient prescription has and be used for all blood disorder persons, makes non-blood system excess-heat, and diease occurrence is in the deficiency of YIN
Interior-heat, YANG unable to attach to somewhere, fire of moxibustion, because of scorching in void, send out and coughs up saliva etc. and demonstrate,prove for telling nosebleed, with non-preferably.Blood must be trembled with fear, and coagulates, and solidifying then cold and heat are handed over and made,
Chest and diaphragm or pain, more increase its disease." " herbal classic is met former ": " Indigo Naturalis, eliminating pathogen in the liver gallbladder dissipate stagnated fire, control maculae caused by violent heat pathogen and puerperal weighs under hematodiarrhoea,
" a thousand pieces of gold " blue blue or green ball with it, the headache of sky row cold and heat, water grinds and takes it.Similar with indigo plant, and the merit of parasite killing of drawing out pus by applying a plaster to the affected part of stopping blooding, seemingly it is better than indigo plant.
Control again dysphagic disease, take its power changing worm also.With white, Borneolum Syntheticum of drowning, blowing sheet, mouthpiece infantile malnutrition is imitated most.”
Borneolum Syntheticum acrid in the mouth, hardship, be slightly cold;GUIXIN, liver, lung meridian;Delicate fragrance a surname dissipate, and has refreshment of having one's ideas straightened out, and heat clearing away dissipates poison, improving acuity of vision and removing nebula
Effect, cure mainly calentura unconsciousness due to high fever, apoplexy syncope due to accumulation of phlegm infantile convulsion, heat-damp in summer blinds clear key, and sore throat is deaf, and aphtha tooth swells, carbuncle sore infantile malnutrition hemorrhoid,
Conjunctival congestion and swelling pain, pterygium.Logical all keys, dissipate stagnated fire, removing nebula improving eyesight, reducing swelling and alleviating pain, and heat clearing away dissipates poison, dissipates fire removing toxic substances.Control mammary gland knot
Block, apoplexy locked mouth, calentura coma, infantile convulsion expectorant fan, deafness with qi stagnation, sore throat, aphtha, otitis media, carbuncle, hemorrhoid, mesh also nebula film, pinworm
Parasitosis." not Lu ": " married woman has difficult labour, and takes Borneolum Syntheticum and grinds into powder a little, is taken after mixing with liquid newly to draw water." Tang Materia Medica: " main trusted subordinate pathogen, rheumatism
Accumulation, deaf.Improving eyesight, goes conjunctival congestion skin nebula.External oculopathy eye in " " Haiyao Bencao, Oversea Materia Medica ": " is main, three worms, control five hemorrhoid, improving eyesight, relieving palpitation, secret
Essence.″
Pseudobulbus Bletillae (Rhizoma Bletillae) property is bitter, sweet, puckery, is slightly cold.Return lung, liver, stomach warp.Function cures mainly astringing to arrest bleeding, detumescence and promoting granulation.Tell for hemoptysis
Blood, traumatic hemorrhage, sore swollen toxin, chapped skin;Pulmonary tuberculosis hemoptysis, ulcer haemorrhage.Shennong's Herbal: " main carbuncle, evil
Skin ulcer, lose cellulitis, the dead flesh of impairment of YIN, pathogen in stomach ";Compendium of Material Medica: " abnormal smells from the patient (root) is bitter, flat, nontoxic.
Radix Arnebiae (Radix Lithospermi) nature and flavor: bitter, cold, Gui Jing: enter percardium, Liver Channel.Function cures mainly: removing heat from blood, invigorates blood circulation, heat clearing away, removing toxic substances.Control warm
Macule, jaundice due to damp-heat, purpura, tell, be defeated in battle, hematuria, stranguria with turbid discharge, constipation with heat retention, burn, eczema, erysipelas, carbuncle and ulcer." herbal classic ": " the main heart
Abdomen pathogen, five types of jaundice, invigorating the spleen and replenishing QI, profit nine orifices, waterway.″
Herba Euphrasiae Regelii, formal name used at school: Euphrasia pectinata Ten, for annual herb plant, herb tool medical value.
Herba Euphrasiae Regelii extract is the aerial parts of the herb of Herba Euphrasiae Regelii, has eye pouch, the effect of the fatigue that disappears.Bitter in the mouth;Cold nature, returns
Warp, returns bladder warp, and function cures mainly heat-clearing and toxic substances removing;Diuresis.Main calentura is thirsty;Headache;Cough due to lung-heat;Laryngopharynx swelling and pain;Pyretic stranguria;Urine
Unfavorable;Aphtha;Carbuncle.
Spica Prunellae is pungent, bitter, cold.Return liver, gallbladder meridian.Effect: clearing away heat-fire, improving eyesight, mass dissipating and swelling eliminating.Conjunctival congestion and swelling pain, have a headache dizzy
Dizzy, mesh pearl nyctalgia.This product bitter cold master enters Liver Channel, and kind removing fire from the liver is with improving eyesight.With controlling flaming up of liver-fire, conjunctival congestion and swelling pain, Folium Mori, chrysanthemum can be joined
Flower, Semen Cassiae etc. are medicinal.Among this product liver heat removing and eyesight improving, nourishing the liver of slightly holding concurrently, to join Radix Angelicae Sinensis, Fructus Lycii, can be used for deficiecny of liver-YIN, mesh pearl aches
Bitterly, to night more particularly;Also Rhizoma Cyperi, Radix Glycyrrhizae use can be joined, as Spica Prunellae dissipates (" Zhang Shi doctor is logical ").Scrofula, goiter.This product acrid in the mouth can dissipate
Knot, bitter cold can expel the heat-evil, and it is medicinal to control pathogenic fire derived from stagnation of liver-QI often to join Bulbus Fritillariae Uninbracteatae, Rhizoma Cyperi etc., and the scrofula of phlegm-fire cohesion, such as Spica Prunellae soup (" surgery
Authentic ");With controlling goiter, the most often join the use such as Thallus Laminariae (Thallus Eckloniae), Radix Scrophulariae, such as Spica Prunellae cream (Golden Mirror of Medicine).
The preparation process of oral pills of the present invention is: take Radix Paeoniae Rubra 1500g, Caulis Spatholobi 1500g, Fructus Corni 1500g, Herba Leonuri
1500g, Radix Bupleuri 1500g, Radix Arnebiae (Radix Lithospermi) 1500g, Radix Rehmanniae Preparata 1500g, Fructus Ligustri Lucidi 1500g, Herba Ecliptae 1500g, Fructus Schisandrae Chinensis 1500g, cover basin
Sub-1500g, Semen Cuscutae 1500g, Herba Epimedii 1500g, Cortex Moutan 1500g, Radix Puerariae 1500g, soak 30 minutes to 1 hour, add
Heat is boiled 30~40 minutes, filters, and filtrate is standby;Filtering residue adds water, second time heating, boils 30~40 minutes, filters, and filtrate is standby
With;Filtering residue adds water, for the third time heated and boiled 30~40 minutes, filters;Three filtrates being combined, heating is concentrated into cream
Shape, after oven drying, becomes fine powder, mixes Mel and be twisted into pill.
The manufacturing process of oral capsule of the present invention is: take Radix Paeoniae Rubra 1200g, Caulis Spatholobi 1100g, Fructus Corni 1100g, Herba Leonuri
Grass 1200g, Radix Bupleuri 1100g, Radix Arnebiae (Radix Lithospermi) 1100g, Radix Rehmanniae Preparata 1200g, Fructus Ligustri Lucidi 1200g, Herba Ecliptae 1200g, Fructus Schisandrae Chinensis 1200g, cover
Basin 1200g, Semen Cuscutae 1200g, Herba Epimedii 1200g, Cortex Moutan 1100g, Radix Puerariae 1200g, by raw material dry in the sun, be cut into coarse grain, so
After be soaked in ethanol 2 hours.Then heating extraction 2 times, each 1-2 hour, united extraction liquid, removes supernatant, so after standing
Rear 100-120 mesh filters, then the ultrafiltration post ultrafiltration that molecular weight is 5000-10000 through damming, ultrafiltrate concentrating under reduced pressure relative density
The extractum of 1.36, stand for standby use when being 80 DEG C, become component 1.The medicinal residues of the crude drug crossed by above-mentioned ethanol extraction again add 10 times
Amount water, heating and refluxing extraction 2 times, each 1~2 hour, 2 extracting solution are merged and stands, become component 2.By component 1 and component
The merging of 2, is then placed in concentrating under reduced pressure tank, decompression recycling ethanol, and being concentrated into liquor strength is 0.6g crude drug/mL, and sucking filtration is extremely
When the relative density of filtrate is 20 DEG C 1.06;Above-mentioned filtrate is after the macroporous adsorptive resins absorption that volume is 10L, with 10 times of trees
The deionized water of fat column volume or distilled water eluting, then with 95% ethanol elution of 5 times of resin column volumes, collect ethanol elution
Liquid, removes solvent, obtains medicated powder and load capsule after drying.
The preparation method of suppository of the present invention: Pseudobulbus Bletillae (Rhizoma Bletillae) 1000g, Indigo Naturalis 1000g, the Borneolum Syntheticum 1000g way of distillation are vaporized into knot
Crystalline substance, then pulverizes, and crosses 100-120 mesh sieve, standby as component 1;Again by remaining crude drug Radix Arnebiae (Radix Lithospermi) 1000g, Radix Sophorae Flavescentis 1000g, Serpentis
Machine tool 1000g, Rhizoma Smilacis Glabrae 1000g, Folium Artemisiae Argyi 1000g, Spica Prunellae 1000g, Herba Euphrasiae Regelii 1000g shred, and are soaked and have been placed in lid
In stainless steel cask, adding 70% ethanol, quality is coarse grained 0.8-1 times, stirs, moistening airtight placement more than 1 hour,
Make fully to expand;After filter plate gauze bag parcel is paved bottom percolator, the drug sample after moistening expansion is mixed pine lane again
Dissipate, then contain powder with rustless steel spoon, load percolator uniformly, fill 10-12 cm thick, even by T-bar pressure, then by above-mentioned behaviour
Making, loading in layer, suitably pressurize, medicated powder loads 2/3 eminence that must not exceed percolator;Upper cover rustless steel hole, medicated powder face
Plate fastens, and opens the baiting valve below percolator, and puts a container, is then slowly added into 70% ethanol;Medicated powder powder to be discharged
Air between Li, and have ethanol to flow out about about 20L, close baiting valve, cover cylinder of filtering, dipping 24 hours, then open material
Valve carries out percolation, controls percolation speed and is generally 1000g medical material outflow per minute 2~3ml, and filtrate puts into liquid container, and will
Ethanol during emptying pours liquid container into;Percolate is merged and stands, as component 2;Component 1 component 2 is mixed into ointment;Choose
50 DEG C~60 DEG C heating and melting of substrate, add ointment cooling and shaping obtained above and make class warhead shape suppository, and ultraviolet is killed virus.
Substrate used by described suppository is selected from: one in semi-synthetic fatty acid glyceride, poloxamer, Polyethylene Glycol, lanoline or
Multiple;Described substrate is heating and melting under the conditions of temperature 50 C~60 DEG C, adds the medicine mastic that described preparation method prepares, water
Bath stirs, and is mixed into the liquid of thickness, is poured in plastic shape-forming pipe, inserts tampon, and cooling and shaping makes bullet-shaped
Suppository;Described tampon is the afterbody tampon with cotton thread.
The detailed directions of described suppository is as follows: drug suppository of the present invention is removed cabinet, takes out stype, pulls out afterbody
Cotton thread, includes in stype bottom vagina, and the most once, cotton thread is stayed external, plays pull-out tampon morning next day, and continuous use 7 days is
One course for the treatment of.
Toxicology test:
Test example 1: acute toxicity test of the present invention
One, test material:
Animal: Kunming mouse, body weight 21-24g, male and female half and half, Shandong University's biology laboratory breeding.Medicine: this
Bright oral capsule.
Two, method:
1, LD50 calculates: using improvement karber's method, mice is randomly divided into 5 groups, often group 10, male and female half and half, by suppository
Dissolving, be made into Cmax, be administered by the maximum allowable capacity of mice, institute is followed successively by 18 to dosage by crude drug amount, and 14.4,11.5,
9.2,7.4 (g.kg-1), after animal fasting (can't help water) 18 hours, are administered in one day (interval half an hour), every time at twice
0.5ml, treats animal dead situation.
2, maximum tolerated dose measures (MTD value): take mice 20, each 10 of male and female.Suppository adds distilled water dissolve, join
Become maximum concentration, by the maximum tolerated dose of animal, can twitch with injection filling hello device and be as the criterion.Animal fasting (can't help water) 18 hours
After, be administered (interval half an hour) at twice in one day, each 0.5ml (every ml 0.36g Han crude drug), total dose be 18g crude drug/
Kg.d, 300 times of quite clinical adult's 50Kg body weight consumption.Treat 7 days continuously after administration.
Three, result of the test:
In LD50 calculates when giving mice with maximum acceptable concentration and maximum allowable capacity (18g/Kg.d), have no little
Mus is dead, does not i.e. measure LD50, seeks maximum tolerated dose only, interim treatment in 7 days, its appetite of animal, activity, hair color, essence
God's states etc. are all normal, grow normal, there are no death.I.e. select and be equivalent to 300 times of doses of clinical dosage, there is no bad instead
Should occur, show that acute toxicity is minimum, MTD > 18g/Kg.d.
Test example 2: acute skin irritation test of the present invention is reported
1, experiment purpose: detect suppository of the present invention to the stimulation/corrosiveness of laboratory animal skin and intensity
2, material and method:
2.1. tested material: title: suppository of the present invention (embodiment 3 method prepares)
2.2. laboratory animal: one grade of big ear white race rabbit, 10, female, body weight 2.1-2.3kg;By University Of Qingdao's medical science
Biology department of institute Experimental Animal Center provides;
2.3. test method:
Select the healthy rabbits 10 that skin is intact, its spinal column both sides, back were cut by hair in first 24 hours in test, go
The left and right each about 4cm × 4cm of gross area.Take tested material 0.2ml during test to be applied on two layers of gauze of 2.5cm × 2.5cm, apply ointment or plaster
In skin of unhairing surface, side, oilpaper covers, immobilization with adhesive tape.Opposite side skin is as blank.After closing 4 hours, remove
Covering, and go to remain tested material with warm water cleaning, area skin is smeared in the treatments in 1,24 and 48 hours after removing tested material
Reaction, and mark.
3, experimental result: any erythema does not occurs in laboratory animal skin, red and swollen, inflammation phenomenon.
4, brief summary: judge according to skin wound repair standards of grading in " disinfection technology standard " (1999), ointment of the present invention
Agent belongs to nonirritant to animal skin stimulus intensity.
Embodiment 3: vaginal mucomembranous irritant test result
1. test method:
After laboratory animal is quarantined 3 days, select 18 above-mentioned healthy rabbits, be randomly divided into three groups, often organize each 6, be respectively as follows:
Blank, excipient control, suppository group of the present invention (by application 5 times of concentration of liquid).Respectively with appropriately sized sterilizing cotton sliver leaching
It is placed in excipient control group and tested material treated animal intravaginal with sterile saline and tested material, contacts 6 with vaginal mucosa little
Time, put to death animal after 24 hours.Taking-up topical vaginal tissue, treats pathological changes situation.
2, result of the test: vaginal mucomembranous irritant test result
Embodiment 4: skin anaphylactic test result
Use suppository of the present invention, carry out inducing and exciting contact test, therapeutic test mice behind 24 hours and 48 hours, all
Lose skin and have the phenomenon such as erythema and edema, with negative control group zero difference.Result shows, this suppository is near to dermoreaction intensity
In zero, i.e. without skin allergic reaction.
Embodiment 5: long term toxicity test data
1, experimental technique
Random for Cavia porcellus part is become 4 groups, often group 15.In guinea pig back spinal column both sides, depilatory is uniformly coated with so that it is de-
Hair scope about 40 square centimeters.Clean depilatory, often organize Cavia porcellus after treating 24 hours and be coated with suppository solution 0.2,0.4 of the present invention respectively
And 0.8ml, respectively containing crude drug 92,184 and 368mg, another group is coated with the every twice-daily of solvent 0.8ml, continuous 30 days, treats Cavia porcellus
Ordinary circumstance, experiment is put to death animal after terminating and is carried out hematology, blood biochemical and pathological examination.
2, result
Above-mentioned three groups of medication Cavia porcellus trunks go to hair-fields, have no that local skin has edema, hyperemia, erythema, petechia and ulcer.
Medication group and control animals chroma of hair, ingest, matched group no significant difference, blood biochemistry checking, the medication such as extremity are movable
Group and matched group are all in normal range.Histopathologic examination, tests each group of heart, liver, kidney and local skin and is showed no obvious disease
Become.Prompting, Chinese medicine suppository long-term prescription of the present invention is showed no obvious toxic action to local skin and whole body important organ.
Result of the test shows: Chinese medicine suppository experiment safety of the present invention.This medicine to group B streptococcus, staphylococcus aureus,
Colibacillary minimal inhibitory concentration is 1: 150, and gonococcus is 1: 150, and Candida albicans is 1: 300, during to 1: 20 dilution factor
Time of killing be 5 minutes, be 10 minutes when 1: 50, be 20 minutes when 1: 100, be 40 minutes when 1: 200, be 8 little when 1: 400
Time.
Clinical trial:
From in November ,-2015 in January, 2014, we are from intending tonifying kidney and nourishing yin side's treatment premature ovarian failure 40 example, and curative effect is preferable, report
Accuse as follows.
1 clinical data
Totally 80 example, secondary amenorrhea, FSH rising person before being 40 years old.Age 17~39 years old, average (33.3 ± 6.8) year;
Amenorrhea 1~11 years, average (3.6 ± 3.7) year.There are hypomenorrhea, or irregular bleeding before amenorrhea, or take place frequently or menstrual blood volume
Few, or amenorrhea suddenly.The wherein i.e. amenorrhea in 3 example menophania 1~3 years, has 2 examples to take traditional Chinese medicine Radix Tripterygii Wilfordii history, and 1 example is suffered from vitiligo and taken Western medicine
(the most not quite clear);Amenorrhea after 2~5 years, has 6 examples to have chronic pelvic inflammatory disease history.There is its mother amenorrhea before 40 years old of 3 examples.There are 3 example secondary
Property is infertile, 1 example primary infertility.All there are hectic fever, perspiration, anxiety, depression, insomnia or hypomnesis, or vaginal dryness, sexual intercourse
The symptoms such as pain or urine urgency-frequency.80 examples are randomly divided into Chinese drug-treated group and Western medicine group.
Western medicine diagnose standard is to occur amenorrhea in more than at least 4 months before 40 years old, and has 2 times or above serum FSH >
40U/L (2 inspection intervals more than 1 month), estradiol level < 73.2pmol/L.
Tcm diagnosis standard is cracked ends before 40 years old, infrequent menstruation, gradually to amenorrhea or menolipsis suddenly, warms sweating, hectic fever
Flushing, dysphoria with feverish sensation in the chest palms and soles, dizziness and tinnitus, soreness of the waist and knees or metapedes are with pain, red dry stool of urinating, emaciated physique, vaginal dryness.B ultrasonic shows son
Palace is less than normal or both sides ovary is less than normal, does not finds follicle or monitors the most developable little follicle of rarely seen only a few, serum E continuously2
Low SI, FSH is significantly raised, red tongue or have crackle, tongue few, thready and rapid pulse or band string.
2 Therapeutic Method
Chinese drug-treated group tonifying kidney and nourishing yin side.Medicinal Radix Rehmanniae Preparata 12g, Radix Paeoniae Rubra 13g, Radix Arnebiae (Radix Lithospermi) 12g, Fructus Corni 11g, Fructus Schisandrae Chinensis 11g, bavin
12g, Fructus Ligustri Lucidi 13g, Herba Ecliptae 12g, Radix Polygoni Multiflori Preparata 12g, Rhizoma Curculiginis 13g, Herba Epimedii 12g, Semen Cuscutae 12g, Radix Puerariae 15g, Cortex Moutan recklessly
12g.Every day 1 dose, take day 2 times, within 3 months, be a course for the treatment of.
Western medicine group premarin, each 0.625mg, every day 1 time, it serve on 22 days;Within 18th day, add medroxyprogestetone acetate, every day
1 time, each 10mg, menstrual onset the 5th day or menstruation do not rise, and drug withdrawal is further continued for taking medicine on the 7th day.Serveing on 3 months is a treatment
Journey.
All treat statistical result after 1 course for the treatment of for two groups.
3 observational techniques
Clinical symptoms and menstrual cycle before and after treatment, through the change of amount, the change of Serum Sex Hormones, ultrasonic show ovary and uterus
Volume, endometrium thickness change.Blood FSH, E2Being checked by the court's epi chamber, use luciferase linked immunosorbent assay, reagent is by method
Biomerieux SA of state produces, and color ultrasound is Japan Nani17.Statistical counting data χ2Inspection, measurement data t is checked.
4 criterions of therapeutical effect
Effective: clinical symptoms and sign disappear, and Endocrinological inspection serum hormone is normal, menstrual onset and continuous more than 2 times
Menorrhea, ovulation function recovers or gestation.Take a turn for the better: cardinal symptom and sign substantially alleviate, and menstruation recovery is risen, but the cycle is not
Normally, Endocrinological inspection serum hormone takes a turn for the better or close to normal.Invalid: symptom, sign and Endocrinological inspection are not improved.
5 therapeutic outcomes
Two groups of comparitive study: two groups of comparitive study there was no significant difference (P > 0.05).It is shown in Table 1.
1 liang of table group comparitive study example (%)
Group | n | Effective | Effectively | Invalid | Total effective rate |
Chinese drug-treated group | 40 | 26 | 3 | 11 | 72.5% |
Western medicine group | 40 | 22 | 5 | 13 | 67.5% |
Two groups of Serum Sex Hormones changes: serum E2Significantly raised, FSH substantially reduces, and comparing before and after two groups of treatments has significantly
Sex differernce (P < 0.05);
Compare after two groups of treatments and there was no significant difference.
2 liang of table group Serum Sex Hormones Indexes Comparison (-x ± s)
After two groups of medications, untoward reaction is compared: the untoward reaction of Chinese drug-treated group is less than Western medicine group, and two groups are compared and have significance poor
Different, (P < 0.05), it is shown in Table 3.
Untoward reaction comparative example after the group medication of 3 liang of table
Group | Feel sick | Headache | Mammary swelling pain | Edema | Abdominal distention | Leucorrhea is many |
Chinese drug-treated group | 2 | 1 | 0 | 0 | 1 | 2 |
Western medicine group | 7 | 6 | 2 | 3 | 2 | 4 |
Two groups of symptoms improvement are compared: two groups of transference cure rates compare significant difference (P < 0.05), is shown in Table 4.
4 liang of table group symptom improves comparative example (%)
C discusses
Premature ovarian failure accounts for the 1%~3.8% of women's total number of persons, is the commonly encountered diseases in gynecological endocrine field.Owing to this type of is suffered from
Person shows as early sending out or primary amenorrhea, estrogen are lowly caused perimenopausal symptom and infertile, therefore belong to traditional Chinese medical science amenorrhea, early send out absolutely
Warp, menopausal syndrome, the category such as infertile.Owing to suffering from a deficiency of the kidney, function senilism is appointed in punching, and the dyspoiesis of menses causes uterus vessels of the uterus (blood
Sea) hollow, depletion of blood can descend and menopause praecox."Fu Qingzhu works on obstetric" cloud: " the most disconnected through water, it appears that kidney water declines and dries up ".Because women is with blood
It is main, and " YIN often being in shortage, YANG often being in excess ", therefore treatment should focus on tonifying kidney and nourishing yin, promoting blood flow to regulate menstruation.In tonifying kidney and nourishing yin Fang Fang, Radix Rehmanniae Preparata is grown
Kidney yin, benefit marrow is monarch drug.Fructus Corni, Radix Polygoni Multiflori, Semen Cuscutae liver and kidney tonifying, support essence and blood.Radix Arnebiae (Radix Lithospermi), Pollen Tyjphae activating blood circulation to dissipate blood stasis, OK
Blood nourishing the liver blood, adjusts punching to appoint.Herba Epimedii liver and kidney tonifying.Fructus Ligustri Lucidi, Herba Ecliptae are ERZHI WAN, effect tonifying kidney and nourishing liver benefit essence.Radix Stellariae
Nourishing YIN and clearing away heat pathogenic fire purging.Radix Puerariae clearing away heat and promoting production of body fluid, has estrogen-like effects according to modern pharmacological research Radix Puerariae, in women's reproduction point
Secrete and there is regulation effect.All medicines share to be played tonifying kidney and nourishing yin altogether and invigorates blood circulation, and takes good care of punching and appoints effect.Invigorating kidney for regulating menstruation Chinese medicine has and delays gonad
Hypofunction effect, has again promotion ovarian function recovery effect, and kidney-nourishing tcm drug has certain tune to female gonad s function simultaneously
By animal experiment study, joint effect, finds that kidney-reinforcing drug has promotion ovary LH/HCG receptor to increase phenomenon.Chinese medicine there may also be rush
Entering the effect that fsh receptor produces, nourishing the liver and kidney, benefit intensive culture blood Chinese medicine have the effect promoting follicular development.With kidney-reinforcing drug in castration
There is estrogen-like to react with mice, therefore think Chinese medicine scalable mankind's follicular development and ovulation.
Premature ovarian failure has obvious heterogeneity to clinical manifestation from the cause of disease to the course of disease, will carry out correct etiological diagnosis,
Dialectical combine with differential diagnosis of diseases, take corresponding treatment strategies, to improve healthy or to delay gonad old and feeble.Modern study is thought, mends
Kidney tune rushes Chinese medicine health invigorating, and regulation gonad axis and immunologic function, even delay gonad aging effect.Clinic shows, the kidney invigorating
Safely, effectively, certainly, untoward reaction is few for treatment premature ovarian failure curative effect, in protection, recovers ovarian function side for the clinical practice of yin nourishing side
Face has certain effect, and its curative effect is equal to simple western medicine treatment, and toxic and side effects is less, low price.
Claims (10)
1. the preparation method of the Chinese medicine composition treating women's ovary senilism, it is characterised in that described Chinese medicine composition bag
Include endo-medicine and external used medicine;
Described endo-medicine is capsule, and its preparation process includes:
A, take crude drug put in ethanol soak, heat extract 2 times, for component 1;
B, medicinal residues extracting in water 2 times, thickening filtration, for component 2;
C, by above two component merge, concentrate, be dried to powder load capsule.
The preparation method of the Chinese medicine composition for the treatment of women's ovary senilism the most according to claim 1, it is characterised in that described
In step a, take in the ethanol of crude drug addition 5-10 times amount and soak 1-2 hour, heating extraction 2 times, each 1-2 hour, merge
Extracting solution, removes supernatant after standing, then 100-120 mesh filters, then the ultrafiltration post that molecular weight is 5000-10000 through damming surpasses
Filter, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, the extractum of 1.36, stand for standby use, become component 1.
The preparation method of the Chinese medicine composition for the treatment of women's ovary senilism the most according to claim 1, it is characterised in that described
In step b, the medicinal residues of the crude drug that above-mentioned ethanol extraction is crossed add weight 10 times amount water, heating and refluxing extraction 2 times, and each 1~2 is little
Time, 2 extracting solution are merged and stands, become component 2.
The preparation method of the Chinese medicine composition for the treatment of women's ovary senilism the most according to claim 1, it is characterised in that described
In step c, by component 1 and the merging of component 2, it is then placed in concentrating under reduced pressure tank, decompression recycling ethanol, is concentrated into liquor strength
For 0.6g crude drug/mL, when the relative density of sucking filtration to filtrate is 20 DEG C 1.06;Above-mentioned filtrate is the macroporous absorption of 10L through volume
After resin column absorption, with deionized water or the distilled water eluting of 10 times of resin column volumes, then by 95% second of 5 times of resin column volumes
Alcohol eluting, collects ethanol elution, removes solvent, obtains medicated powder and load capsule after drying.
5. the preparation method of the Chinese medicine composition treating women's ovary senilism, it is characterised in that described Chinese medicine composition bag
Include endo-medicine and external used medicine;
Described external used medicine is suppository, and its preparation method includes:
A. take the Pseudobulbus Bletillae (Rhizoma Bletillae), Indigo Naturalis, the Borneolum Syntheticum way of distillation are vaporized into crystallization, pulverize dusting cover stand-by, as component 1;
B. remaining raw material ethanol is extracted, concentrate, as component 2;
C. adding substrate after component 1, component 2 being mixed to be in harmonious proportion, suppository, sterilization pack are made in sizing.
The preparation method of the Chinese medicine composition for the treatment of women's ovary senilism the most according to claim 5, it is characterised in that described
In step a, first the crude drug Pseudobulbus Bletillae (Rhizoma Bletillae), Indigo Naturalis, Borneolum Syntheticum steam method are distilled, obtain crystal, then pulverize, cross 100-120
Mesh sieve, standby as component 1;In described step b, then remaining crude drug is shredded, is soaked and be placed in lid stainless steel cask,
Adding 70% ethanol, quality is coarse grained 0.8-1 times, stirs, moistening airtight placement more than 1 hour, makes fully to expand;
By bottom percolator filter plate gauze bag parcel pave after again the drug sample after moistening expansion is mixed pine do dissipate, then with stainless
Powder contained by steel spoon, loads percolator uniformly, fills 10-12 cm thick, even by T-bar pressure, then presses aforesaid operations, dress in layer
Entering, suitably pressurize, medicated powder loads 2/3 eminence that must not exceed percolator;Medicated powder face upper cover rustless steel orifice plate fastens, and opens percolation
Cylinder baiting valve below, and put a container, then it is slowly added into 70% ethanol;Air between medicated powder powder to be discharged, and
There is ethanol to flow out about about 20L, close baiting valve, cover cylinder of filtering, dipping 24 hours, then open baiting valve and carry out percolation, control
Percolation speed is generally 1000g medical material outflow per minute 2~3ml, and filtrate puts into liquid container, and is fallen by ethanol during emptying
Enter liquid container;Percolate is merged and stands, as component 2;Component 1 component 2 is mixed into ointment;Choose substrate 50 DEG C~60 DEG C to add
Heat is melted, and adds ointment cooling and shaping obtained above and makes class warhead shape suppository, and ultraviolet is killed virus.
The preparation method of the Chinese medicine composition for the treatment of women's ovary senilism the most according to claim 5, it is characterised in that described
Substrate used by suppository is selected from: one or more in semi-synthetic fatty acid glyceride, poloxamer, Polyethylene Glycol, lanoline;
Described substrate is heating and melting under the conditions of temperature 50 C~60 DEG C, adds the medicine mastic that described preparation method prepares, and water-bath is stirred
Mixing uniformly, be mixed into the liquid of thickness, be poured in plastic shape-forming pipe, insert tampon, cooling and shaping makes bullet-shaped suppository;
Described tampon is the afterbody tampon with cotton thread.
8. the Chinese medicine composition treating women's ovary senilism, it is characterised in that be made up of endo-medicine and external used medicine,
Described endo-medicine includes the crude drug of following weight portion: Radix Paeoniae Rubra 10~20 parts, Caulis Spatholobi 10~20 parts, Fructus Corni 10~
20 parts, Herba Leonuri 10~20 parts, Radix Bupleuri 10~20 parts, Radix Arnebiae (Radix Lithospermi) 10~20 parts, Radix Rehmanniae Preparata 10~20 parts, Fructus Ligustri Lucidi 10~20 parts, drought
Lotus grass 10~20 parts, Fructus Schisandrae Chinensis 10~20 parts, Fructus Rubi 10~20 parts, Semen Cuscutae 10~20 parts, Herba Epimedii 10~20 parts, Cortex Moutan
10~20 parts, Radix Puerariae 10~20 parts;
Described external used medicine includes the crude drug of following parts by weight: Radix Arnebiae (Radix Lithospermi) 10~20 parts, Radix Sophorae Flavescentis 10~20 parts, Fructus Cnidii 10~
20 parts, Rhizoma Smilacis Glabrae 10~20 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10~20 parts, Folium Artemisiae Argyi 10~20 parts, Indigo Naturalis 10~20 parts, Spica Prunellae 10~20 parts, ice
Sheet 10~20 parts, Herba Euphrasiae Regelii 10~20 parts.
Treat the Chinese medicine composition of women's ovary senilism the most according to claim 8, it is characterised in that described endo-medicine is also
Crude drug including following weight portion: Radix Paeoniae Rubra 10~15 parts, Caulis Spatholobi 10~15 parts, Fructus Corni 10~15 parts, Herba Leonuri 10~
15 parts, Radix Bupleuri 10~15 parts, Radix Arnebiae (Radix Lithospermi) 10~15 parts, Radix Rehmanniae Preparata 10~15 parts, Fructus Ligustri Lucidi 10~15 parts, Herba Ecliptae 10~15 parts, five
Taste 10~20 parts, Fructus Rubi 10~20 parts, Semen Cuscutae 10~20 parts, Herba Epimedii 10~20 parts, Cortex Moutan 10~20 parts, Radix Puerariae 10
~20 parts;
Described external used medicine also includes the crude drug of following parts by weight: Radix Arnebiae (Radix Lithospermi) 10~15 parts, Radix Sophorae Flavescentis 10~15 parts, Fructus Cnidii 10
~15 parts, Rhizoma Smilacis Glabrae 10~15 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10~15 parts, Folium Artemisiae Argyi 10~20 parts, Indigo Naturalis 10~20 parts, Spica Prunellae 10~20 parts,
Borneolum Syntheticum 10~20 parts, Herba Euphrasiae Regelii 10~20 parts.
Treat the Chinese medicine composition of women's ovary senilism the most according to claim 8, it is characterised in that described endo-medicine
Also the crude drug of following weight portion is included: Radix Paeoniae Rubra 10~20 parts, Caulis Spatholobi 10~20 parts, Fructus Corni 10~20 parts, Herba Leonuri 10
~20 parts, Radix Bupleuri 10~20 parts, Radix Arnebiae (Radix Lithospermi) 10~20 parts, Radix Rehmanniae Preparata 10~20 parts, Fructus Ligustri Lucidi 10~20 parts, Herba Ecliptae 10~20 parts,
Fructus Schisandrae Chinensis 10~15 parts, Fructus Rubi 10~15 parts, Semen Cuscutae 10~15 parts, Herba Epimedii 10~15 parts, Cortex Moutan 10~15 parts, Radix Puerariae
10~15 parts;
Described external used medicine also includes the crude drug of following parts by weight: Radix Arnebiae (Radix Lithospermi) 10~20 parts, Radix Sophorae Flavescentis 10~20 parts, Fructus Cnidii 10
~20 parts, Rhizoma Smilacis Glabrae 10~20 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10~20 parts, Folium Artemisiae Argyi 10~15 parts, Indigo Naturalis 10~15 parts, Spica Prunellae 10~15 parts,
Borneolum Syntheticum 10~15 parts, Herba Euphrasiae Regelii 10~15 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610443754.3A CN106038802A (en) | 2016-06-21 | 2016-06-21 | Preparation method of traditional Chinese medicinal composition for treating premature ovarian failure of women and traditional Chinese medicinal composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610443754.3A CN106038802A (en) | 2016-06-21 | 2016-06-21 | Preparation method of traditional Chinese medicinal composition for treating premature ovarian failure of women and traditional Chinese medicinal composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106038802A true CN106038802A (en) | 2016-10-26 |
Family
ID=57168522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610443754.3A Withdrawn CN106038802A (en) | 2016-06-21 | 2016-06-21 | Preparation method of traditional Chinese medicinal composition for treating premature ovarian failure of women and traditional Chinese medicinal composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106038802A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112791153A (en) * | 2021-04-01 | 2021-05-14 | 延安大学附属医院 | Traditional Chinese medicine for treating premature ovarian failure and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1175456A (en) * | 1997-09-10 | 1998-03-11 | 陈二民 | Traditional Chinese medicine composition for treatment of female dysgenesis |
CN103721131A (en) * | 2013-12-30 | 2014-04-16 | 青岛恒波仪器有限公司 | Traditional Chinese medicinal suppository for treating female chronic pelvic inflammation and preparation method thereof |
CN104274788A (en) * | 2014-11-05 | 2015-01-14 | 青岛恒波仪器有限公司 | Traditional Chinese medicine composition for treating morbid leucorrhea due to liver-fire and damp-heat in women and preparation method of traditional Chinese medicine composition |
CN104306637A (en) * | 2014-11-05 | 2015-01-28 | 青岛恒波仪器有限公司 | Traditional Chinese medicine composition for treating morbid leucorrhea of women with damp abundance due to spleen asthenia syndrome and preparation method of traditional Chinese medicine composition |
CN104906465A (en) * | 2015-06-25 | 2015-09-16 | 青岛大学附属医院 | Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof |
-
2016
- 2016-06-21 CN CN201610443754.3A patent/CN106038802A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1175456A (en) * | 1997-09-10 | 1998-03-11 | 陈二民 | Traditional Chinese medicine composition for treatment of female dysgenesis |
CN103721131A (en) * | 2013-12-30 | 2014-04-16 | 青岛恒波仪器有限公司 | Traditional Chinese medicinal suppository for treating female chronic pelvic inflammation and preparation method thereof |
CN103721131B (en) * | 2013-12-30 | 2016-06-01 | 赵玉妹 | A kind of Chinese medicine suppository and its preparation method treating women's chronic pelvic inflammatory disease |
CN104274788A (en) * | 2014-11-05 | 2015-01-14 | 青岛恒波仪器有限公司 | Traditional Chinese medicine composition for treating morbid leucorrhea due to liver-fire and damp-heat in women and preparation method of traditional Chinese medicine composition |
CN104306637A (en) * | 2014-11-05 | 2015-01-28 | 青岛恒波仪器有限公司 | Traditional Chinese medicine composition for treating morbid leucorrhea of women with damp abundance due to spleen asthenia syndrome and preparation method of traditional Chinese medicine composition |
CN104906465A (en) * | 2015-06-25 | 2015-09-16 | 青岛大学附属医院 | Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112791153A (en) * | 2021-04-01 | 2021-05-14 | 延安大学附属医院 | Traditional Chinese medicine for treating premature ovarian failure and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102145064B (en) | Traditional Chinese medicine composition for treating senile vaginitis and preparation method thereof | |
CN102847063B (en) | Traditional Chinese medicinal composition for treating qi and blood deficiency blood stasis type diabetic feet, and its preparation method | |
CN102178804B (en) | Chinese medicinal composition for treating perianal eczema and preparation method thereof | |
CN105343625A (en) | Taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder and preparation method thereof | |
CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
CN104274788A (en) | Traditional Chinese medicine composition for treating morbid leucorrhea due to liver-fire and damp-heat in women and preparation method of traditional Chinese medicine composition | |
CN102000164B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
CN102988675B (en) | Traditional Chinese medicine combination for treating chronic prostatitis and preparation method thereof | |
CN103041262B (en) | Traditional Chinese medicine enema for curing chronic prostatitis and preparing method thereof | |
CN104587302A (en) | Traditional Chinese medicine preparation for treating acute appendicitis | |
CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
CN101637552B (en) | Chinese medicine compound for controlling chronic pelvic inflammation | |
CN106038802A (en) | Preparation method of traditional Chinese medicinal composition for treating premature ovarian failure of women and traditional Chinese medicinal composition | |
CN103041263B (en) | Traditional Chinese medicine rectal administration suppository for curing chronic prostatitis and preparing method thereof | |
CN105233056A (en) | Rhubarb oral liquid capable of clearing away heat and removing dampness and beneficial to choleresis and detoxification and preparation method of rhubarb oral liquid | |
CN106177451A (en) | The Chinese medicine suppository preparation method for the treatment of women's ovary senilism and suppository thereof | |
CN104840865A (en) | Traditional Chinese medicine preparation for treating gouty arthritis | |
CN104324185A (en) | Traditional Chinese medicine composition for treating leukorrhagia and preparation method thereof | |
CN104367946A (en) | Traditional Chinese medicine suppository for treating chronic endometritis and preparation method thereof | |
CN105998290A (en) | Traditional Chinese medicine composition for treating early woman amenorrhea and preparing method thereof | |
CN105943816A (en) | Traditional Chinese medicine composition for treating premature ovarian failure of females and preparation method thereof | |
CN105535674A (en) | A medicine for treating chronic cervicitis | |
CN105288315A (en) | Christina loosestrife herb oral liquid for clearing away heat, removing dampness, benefiting bile and expelling toxin and preparation method of christina loosestrife herb oral liquid | |
CN104474467A (en) | Traditional Chinese medicine composition for treating Qi-stagnation and blood stasis type dysmenorrheal and preparation method of traditional Chinese medicine composition | |
CN105920359A (en) | Traditional Chinese medicine suppository for treating premature ovarian failure of women and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161026 |
|
WW01 | Invention patent application withdrawn after publication |